Ecopetrol SA vs Inovio Pharmaceuticals Inc — how do they compare? Ecopetrol SA trades at $15.78 (market cap $30.44B), while Inovio Pharmaceuticals Inc trades at $1.13 (market cap $96.26M). The key difference: Ecopetrol SA is far larger — about 316.2× Inovio Pharmaceuticals Inc's market cap, and Ecopetrol SA pays a 4.06% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| EC | INO | |
|---|---|---|
Market Cap | $30.44B | $96.26M |
Sector | Energy | Health |
52-Week High | $16.58 | $2.87 |
52-Week Low | $8.29 | $1.05 |
Enterprise Value | $58.23B | $67.27M |
Dividend Yield | 4.06% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.14, down 1.72% today, with a bearish technical signal from moving averages. The company shows minimal revenue of $65,340 in 2025 but has consistently beaten EPS estimates recently. Cash flow remains negative, though operating expenses are declining. A key FDA decision on INO-3107 is expected by October 30, 2026, representing a major catalyst.
The outlook hinges on regulatory approval for INO-3107. While analyst consensus is moderately bullish (53% buy ratings), significant financial losses and high valuation ratios pose substantial risks. The stock is a high-risk, event-driven investment dependent on successful drug commercialization to reverse its negative profitability trends.
Trailing returns across standard periods
Latest headlines on both assets
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →